EditorialEditorial

Optimization of regional nodal irradiation in the era of sentinel lymph node biopsy

Zhao Bi, Xue’er Wang, Pengfei Qiu, Peng Chen and Yongsheng Wang
Cancer Biology & Medicine February 2023, 20 (2) 89-92; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0625

References

  1. 1.↵
    2. Ozcan LC,
    3. Giuliano AE.
    Is axillary lymph node dissection necessary after a positive sentinel lymph node biopsy? Adv Surg. 2017; 51: 165–78.
    OpenUrl
  2. 2.↵
    2. Krag DN,
    3. Anderson SJ,
    4. Julian TB,
    5. Brown AM,
    6. Harlow SP,
    7. Costantino JP, et al.
    Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomized phase 3 trial. Lancet Oncol. 2010; 11: 927–33.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    2. Giuliano AE,
    3. Ballman K,
    4. McCall L,
    5. Beitsch P,
    6. Whitworth PW,
    7. Blumencranz P, et al.
    Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeon Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016; 264: 413–20.
    OpenUrlCrossRefPubMed
  4. 4.↵
    2. Donker M,
    3. van Tienhoven G,
    4. Straver ME,
    5. Meijnen P,
    6. van de Velde CJ,
    7. Mansel RE, et al.
    Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomized, multicenter, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014; 15: 1303–10.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    2. Li JJ,
    3. Cheng JY,
    4. Liu GY,
    5. Hou Y,
    6. Di G,
    7. Yang B, et al.
    Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial. Cancer Biol Med. 2022; 19: 1100–8.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    2. Jagsi R,
    3. Chadha M,
    4. Moni J,
    5. Ballman K,
    6. Laurie F,
    7. Buchholz TA, et al.
    Radiation field design in the ACOSOG Z0011 (Alliance) trial. J Clin Oncol. 2014; 32: 3600.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    2. Morrow M.
    De-escalating breast cancer surgery: what’s next? In: 17th Chinese Breast Cancer Conference. 2022: General Section 4.
  8. 8.↵
    2. Bi Z,
    3. Chen JJ,
    4. Liu PC,
    5. Chen P,
    6. Wang WL,
    7. Liu YB, et al.
    Candidates of genomic tests in HR+/HER2-breast cancer patients with 1-2 positive sentinel lymph node without axillary lymph node dissection: analysis from multicentric cohorts. Front Oncol. 2021; 11: 722325.
  9. 9.↵
    2. McGale P,
    3. Taylor C,
    4. Correa C,
    5. Cutter D,
    6. Duane F, et al.
    EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014; 383: 2127–35.
    OpenUrlCrossRefPubMed
  10. 10.↵
    2. Yang ZB,
    3. Lan XW,
    4. Huang Z,
    5. Yang Y,
    6. Tang Y,
    7. Jing H, et al.
    Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes. Breast. 2020; 53: 143–51.
    OpenUrl
  11. 11.↵
    2. Wang YJ,
    3. Chen JY.
    Radiotherapeutic strategies for breast cancer patients in accordance with ACOSOG Z0011 study criteria. Chin J Pract Surg. 2018; 38: 1270–6.
    OpenUrl
  12. 12.↵
    2. Katz A,
    3. Smith BL,
    4. Golshan M,
    5. Niemierko A,
    6. Kobayashi W,
    7. Raad RA, et al.
    Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008; 26: 2093–8.
    OpenUrlAbstract/FREE Full Text
  13. 13.
    2. Xie X,
    3. Tan W,
    4. Chen B,
    5. Huang X,
    6. Peng C,
    7. Yan S, et al.
    Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical-related features for axillary lymph node metastasis in early-stage invasive breast cancer. Int J Cancer. 2018; 142: 1901–10.
    OpenUrl
  14. 14.
    2. Sa-Nguanraksa D,
    3. O-Charoenrat E,
    4. Kulprom A,
    5. Samarnthai N,
    6. Lohsiriwat V,
    7. Nimpoonsri K, et al.
    Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand. Breast Cancer. 2019; 26: 471–7.
    OpenUrl
  15. 15.↵
    2. Unal B,
    3. Gur AS,
    4. Beriwal S,
    5. Tang G,
    6. Johnson R,
    7. Ahrendt G, et al.
    Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Int J Radiat Oncol Biol Phys. 2009; 75: 1035–40.
    OpenUrlPubMed
  16. 16.↵
    2. Whelan TJ,
    3. Olivotto IA,
    4. Parulekar WR,
    5. Ackerman I,
    6. Chua BH,
    7. Nabid A, et al.
    Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015; 373: 307–16.
    OpenUrlCrossRefPubMed
  17. 17.
    2. Poortmans PM,
    3. Collette S,
    4. Kirkove C,
    5. Van Limbergen E,
    6. Budach V,
    7. Struikmans H, et al.
    Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015; 373: 317–27.
    OpenUrlCrossRefPubMed
  18. 18.↵
    2. Poortmans PM,
    3. Weltens C,
    4. Fortpied C,
    5. Kirkove C,
    6. Peignaux-Casasnovas K,
    7. Budach V, et al.
    Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. Lancet Oncol. 2020; 21: 1602–10.
    OpenUrlCrossRefPubMed
  19. 19.↵
    2. Budach W,
    3. Bölke E,
    4. Kammers K,
    5. Gerber PA,
    6. Nestle-Krämling C,
    7. Matuschek C.
    Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials-an update. Radiat Oncol. 2015; 10: 258.
    OpenUrlCrossRefPubMed
  20. 20.↵
    2. Thorsen LB,
    3. Offersen BV,
    4. Danø H,
    5. Berg M,
    6. Jensen I,
    7. Pedersen AN, et al.
    DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol. 2016; 34: 314–20.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    2. Qiu PF,
    3. Wang XE,
    4. Wang YS.
    Indications for individual internal mammary node irradiation. Lancet Oncol. 2021; 22: e40.
  22. 22.↵
    2. Wang Y,
    3. Lv Q,
    4. Zhu S,
    5. Zhao W,
    6. Yang G,
    7. Huang Y, et al.
    Prospective, multicenter, clinical validation study of internal mammary sentinel lymph node biopsy followed by internal mammary lymph node dissection with the modified injection technique (CBCSG026/27). In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, TX. Cancer Res. 2020; 80: Abstract nr P1-20-14.
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section